128 related articles for article (PubMed ID: 32950408)
21. Staging of breast cancer: new recommended standard procedure.
Ravaioli A; Pasini G; Polselli A; Papi M; Tassinari D; Arcangeli V; Milandri C; Amadori D; Bravi M; Rossi D; Fattori PP; Pasquini E; Panzini I
Breast Cancer Res Treat; 2002 Mar; 72(1):53-60. PubMed ID: 12000220
[TBL] [Abstract][Full Text] [Related]
22. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
[TBL] [Abstract][Full Text] [Related]
23. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
Al-Muqbel KM; Yaghan RJ
Medicine (Baltimore); 2016 May; 95(21):e3753. PubMed ID: 27227942
[TBL] [Abstract][Full Text] [Related]
25. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
26. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.
Puglisi F; Follador A; Minisini AM; Cardellino GG; Russo S; Andreetta C; Di Terlizzi S; Piga A
Ann Oncol; 2005 Feb; 16(2):263-6. PubMed ID: 15668281
[TBL] [Abstract][Full Text] [Related]
27. CT staging of loco-regional breast cancer recurrence. A worthwhile practice?
Tennant S; Evans A; Macmillan D; Lee A; Cornford E; James J; Ellis I
Clin Radiol; 2009 Sep; 64(9):885-90. PubMed ID: 19664478
[TBL] [Abstract][Full Text] [Related]
28. [Indication for bone scans in early breast cancer staging].
de la Cueva L; Liévano P; Navarro P; Arroyo E; Añaños M; González M; García MC; Fuerte A; Colmenarejo F; Baringo T; Abós MD
Rev Esp Med Nucl; 2009; 28(6):273-7. PubMed ID: 19995533
[TBL] [Abstract][Full Text] [Related]
29. Staging of breast cancer: what standards should be used in research and clinical practice?
Ravaioli A; Tassinari D; Pasini G; Polselli A; Papi M; Fattori PP; Pasquini E; Masi A; Alessandrini F; Canuti D; Panzini I; Drudi G
Ann Oncol; 1998 Nov; 9(11):1173-7. PubMed ID: 9862046
[TBL] [Abstract][Full Text] [Related]
30. Evidence for selective use of bone scans in early stage breast cancer.
Hadley D; Fowble B; Torosian MH
Oncol Rep; 1998; 5(4):991-3. PubMed ID: 9625860
[TBL] [Abstract][Full Text] [Related]
31. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
[TBL] [Abstract][Full Text] [Related]
32. [Is staging bone scan useful in patients with small invasive breast carcinoma?].
Simon E; Marret H; Barillot I; Bougnoux A; Hajjaji N; Body G
Gynecol Obstet Fertil; 2009 Jan; 37(1):91-4. PubMed ID: 19059802
[TBL] [Abstract][Full Text] [Related]
33. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
Prior JO; Barghouth G; Delaloye JF; Leyvraz S; Bischof Delaloye A
Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer.
Khansur T; Haick A; Patel B; Balducci L; Vance R; Thigpen T
Am J Clin Oncol; 1987 Apr; 10(2):167-70. PubMed ID: 3565316
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
Niikura N; Hashimoto J; Kazama T; Koizumi J; Ogiya R; Terao M; Oshitanai R; Morioka T; Tsuda B; Okamura T; Saito Y; Iwaisako K; Iwamoto T; Hayashi N; Imai Y; Tokuda Y
Breast Cancer; 2016 Jul; 23(4):662-7. PubMed ID: 26037335
[TBL] [Abstract][Full Text] [Related]
36. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.
Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L
Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Bone Lesions with
van Es SC; Velleman T; Elias SG; Bensch F; Brouwers AH; Glaudemans AWJM; Kwee TC; Iersel MW; Maduro JH; Oosting SF; de Vries EGE; Schröder CP
J Nucl Med; 2021 Feb; 62(2):177-183. PubMed ID: 32817140
[TBL] [Abstract][Full Text] [Related]
38. Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer.
Parker SJ; Pond GR; Agarwal N; Alex A; Heilbrun ME; Sonpavde G
Clin Genitourin Cancer; 2017 Feb; 15(1):53-59. PubMed ID: 27338517
[TBL] [Abstract][Full Text] [Related]
39. Reappraisal of the baseline bone scan in breast cancer.
Coleman RE; Rubens RD; Fogelman I
J Nucl Med; 1988 Jun; 29(6):1045-9. PubMed ID: 3373314
[TBL] [Abstract][Full Text] [Related]
40. Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient.
Groves AM; Beadsmoore CJ; Cheow HK; Balan KK; Courtney HM; Kaptoge S; Win T; Harish S; Bearcroft PW; Dixon AK
Eur Radiol; 2006 May; 16(5):1066-73. PubMed ID: 16402253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
